NEUES VERFAHREN

Patent europeic · EP2571902 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2571902
Numer da la dumonda
EP11721756
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
18-05-2011
Publitgà
27-03-2013
Concedì
10-07-2019
La protecziun finescha il pli tard
17-05-2031
Proxima taxa annuala scadenta
31-05-2026
Classas IPC
C08B 37/00 (2006.01)
C12P 19/04 (2006.01)
Prioritad
GB 201008401 20.05.2010
Dumonda PCT
PCT/EP2011/058016 18.05.2011
Publicaziun PCT
WO2011/144645 24.11.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  2. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  3. 01-06-2023

    Midada

    Published in Swissreg on 01.06.2023

  4. 05-09-2019

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 05.09.2019

  5. 10-07-2019

    Concedì

    Published in Swissreg on 10.07.2019

Partidas

Possessur

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut, 89, 1330 Rixensart, BE

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

MANCUSO, Vincent

B-1330 Rixensart, BE

GELDHOF, Geoffroy

B-1330 Rixensart, BE

CHARLES, Philippe

B-1330 Rixensart, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.